Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

  • Showing results for a modified search because your search retrieved no results.
1.

1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes.

Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK, Burgess JR, Teegarden D.

J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):122-6. doi: 10.1016/j.jsbmb.2008.09.006. Epub 2008 Sep 17.

3.

Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate.

Tenenhouse HS, Martel J, Gauthier C, Zhang MY, Portale AA.

Endocrinology. 2001 Mar;142(3):1124-9.

PMID:
11181527
4.

Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas.

Jones G, Ramshaw H, Zhang A, Cook R, Byford V, White J, Petkovich M.

Endocrinology. 1999 Jul;140(7):3303-10.

PMID:
10385427
5.

Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.

Segersten U, Björklund P, Hellman P, Akerström G, Westin G.

Clin Endocrinol (Oxf). 2007 Mar;66(3):399-404.

PMID:
17302875
6.
7.

25-hydroxyvitamin D₃ and 1,25-dihydroxyvitamin D₃ promote the differentiation of human subcutaneous preadipocytes.

Nimitphong H, Holick MF, Fried SK, Lee MJ.

PLoS One. 2012;7(12):e52171. doi: 10.1371/journal.pone.0052171. Epub 2012 Dec 18.

8.

A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.

Lechner D, Manhardt T, Bajna E, Posner GH, Cross HS.

J Pharmacol Exp Ther. 2007 Mar;320(3):1119-26. Epub 2006 Dec 20.

9.

25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.

Segersten U, Holm PK, Björklund P, Hessman O, Nordgren H, Binderup L, Akerström G, Hellman P, Westin G.

Breast Cancer Res. 2005;7(6):R980-6. Epub 2005 Oct 6.

11.
12.

Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.

Kállay E, Bises G, Bajna E, Bieglmayer C, Gerdenitsch W, Steffan I, Kato S, Armbrecht HJ, Cross HS.

Carcinogenesis. 2005 Sep;26(9):1581-9. Epub 2005 May 19.

PMID:
15905206
13.

High fat diet-Induced obesity alters vitamin D metabolizing enzyme expression in mice.

Park JM, Park CY, Han SN.

Biofactors. 2015 May 6;41(3):175-82. doi: 10.1002/biof.1211. Epub 2015 Apr 22.

PMID:
25904060
14.

25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells.

Lou YR, Laaksi I, Syvälä H, Bläuer M, Tammela TL, Ylikomi T, Tuohimaa P.

FASEB J. 2004 Feb;18(2):332-4. Epub 2003 Dec 4.

PMID:
14657005
15.

Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.

Anderson PH, O'Loughlin PD, May BK, Morris HA.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):111-3.

PMID:
15225756
16.

Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.

Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G.

Endocrinology. 2005 Feb;146(2):825-34. Epub 2004 Oct 21.

PMID:
15498883
17.

Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney.

Akeno N, Matsunuma A, Maeda T, Kawane T, Horiuchi N.

J Endocrinol. 2000 Mar;164(3):339-48.

18.
19.

Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells.

Armbrecht HJ, Hodam TL, Boltz MA.

Arch Biochem Biophys. 2003 Jan 15;409(2):298-304.

PMID:
12504896
20.

25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.

Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ.

Kidney Int. 2006 Aug;70(4):654-9. Erratum in: Kidney Int. 2006 Sep;70(6):1190.

Supplemental Content

Support Center